Article
Variations of BRAF mutant allele percentage in melanomas.
BMC cancer - 4 Jul 2015
Hélias-Rodzewicz Zofia, Funck-Brentano Elisa, Baudoux Laure, Jung Chan Kwon, Zimmermann Ute, Marin Cristi, Clerici Thierry, Le Gall Catherine, Peschaud Frédérique, Taly Valérie, Saiag Philippe, Emile Jean-François
Abstract excerpt
BACKGROUND: BRAF mutations are present in 40% of human skin melanomas. Mutated tumors with an increased percentage of BRAF mutant alleles (BRAF-M%) may have a better response to RAF/MEK inhibitors. We evaluated the BRAF-M% in melanomas, and the genetic causes of its variation. METHODS: BRAF-M% was quantified by pyrosequencing, real-time PCR (rtPCR) and/or picoliter-droplet PCR (dPCR). BRAF mutant expression was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
